Breast Biopsy Market Share

APAC Market Forecast

The breast biopsies market in Asia Pacific, is expected to hold the largest revenue share of around 35% by the end of 2037. The growth of the region is likely to be mainly due to the increase in the percentage of the aging population in the Asia Pacific region. As older women have a higher risk of breast cancer. Also, health organizations are increasingly promoting breast cancer screening programs, including mammograms and breast biopsies.

North America Market Statistics

The breast biopsy market in the North America is expected to account for the second largest market share, around 25% during the projection period. The growth of the market in this region can be mainly attributed to the increasing technological advancement in breast biopsy technology in North America. There have been significant advances in the design and function of biopsy needles and other biopsy devices in North America, making breast biopsies more precise and less invasive. This has led to an increase in demand for breast biopsy procedures in the region. All insurance plans in North America cover breast biopsy procedures, making the procedure easier for patients to access, leading to increased demand